Beam Therapeutics Inc.
BEAM
$26.75
$0.240.91%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -122.68M | -94.32M | 244.30M | -112.73M | -102.14M |
| Total Depreciation and Amortization | 5.41M | 5.61M | 5.67M | 5.56M | 5.54M |
| Total Amortization of Deferred Charges | 64.00K | 35.00K | -- | -- | -- |
| Total Other Non-Cash Items | 22.89M | 15.78M | -231.39M | 32.81M | 16.71M |
| Change in Net Operating Assets | 28.22M | -55.62M | -101.86M | -7.12M | 3.44M |
| Cash from Operations | -66.10M | -128.51M | -83.29M | -81.48M | -76.45M |
| Capital Expenditure | -2.41M | -2.23M | -3.73M | -5.01M | -3.14M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | -78.00K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.46M | 27.50M | 112.14M | 70.74M | -167.28M |
| Cash from Investing | -9.88M | 25.27M | 108.41M | 65.66M | -170.41M |
| Total Debt Issued | 0.00 | 93.89M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.52M | 3.54M | 1.89M | 1.68M | 1.11M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -813.00K | -- | -- | -- |
| Cash from Financing | 7.52M | 96.61M | 1.89M | 1.68M | 1.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -68.45M | -6.64M | 27.00M | -14.15M | -245.75M |